These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 328387)

  • 1. Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.
    Schorlemmer HU; Bitter-Suermann D; Allison AC
    Immunology; 1977 Jun; 32(6):929-40. PubMed ID: 328387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage responses to mouldy hay dust, Micropolyspora faeni and zymosan, activators of complement by the alternative pathway.
    Schorlemmer HU; Edwards JH; Davies P; Allison AC
    Clin Exp Immunol; 1977 Feb; 27(2):198-207. PubMed ID: 849651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of activated complement components on enzyme secretion by macrophages.
    Schorlemmer HU; Allison AC
    Immunology; 1976 Nov; 31(5):781-8. PubMed ID: 992710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative studies of the secretion of complement component C3 by resident, elicited and activated macrophages. Comparison with C2, C4 and lysosomal enzyme release.
    Zimmer B; Hartung HP; Scharfenberger G; Bitter-Suermann D; Hadding U
    Eur J Immunol; 1982 May; 12(5):426-30. PubMed ID: 7094993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmonellae activate complement differentially via the alternative pathway depending on the structure of their lipopolysaccharide O-antigen.
    Liang-Takasaki CJ; Grossman N; Leive L
    J Immunol; 1983 Apr; 130(4):1867-70. PubMed ID: 6187823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage secretion and the complement cleavage product C3a in the pathogenesis of infections by mycoplasmas and L-forms of bacteria and in immunity to these organisms.
    Taylor-Robinson D; Schorlemmer HU; Furr PM; Allison AC
    Clin Exp Immunol; 1978 Sep; 33(3):486-94. PubMed ID: 367651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of zymosan and of activated properdin with factor D-depleted guinea pig serum: implications for the mechanism of initial C3 cleavage via the alternative complement pathway.
    Brade V; Bentley C; Bitter-Suermann D; Hadding U
    Z Immunitatsforsch Immunobiol; 1977 Feb; 152(5):402-14. PubMed ID: 556571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
    Mosser DM; Edelson PJ
    J Immunol; 1984 Mar; 132(3):1501-5. PubMed ID: 6363545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the classical and alternate pathways of complement by Corynebacterium parvum.
    McBride WH; Weir DM; Kay AB; Pearce D; Caldwell JR
    Clin Exp Immunol; 1975 Jan; 19(1):143-7. PubMed ID: 1204238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective release of lysosomal acid hydrolases from mouse peritoneal macrophages by stimuli of chronic inflammation.
    Schorlemmer HU; Davies P; Hylton W; Gugig M; Allison AC
    Br J Exp Pathol; 1977 Jun; 58(3):315-26. PubMed ID: 871380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of phagocytic activity and new appearance of a C4b (guinea pig) recognizing capability in peritoneal macrophages from Corynebacterium parvum and thioglycollate-stimulated mice.
    Wellek B; Kessel G; Loos M; Hahn H
    Monogr Allergy; 1977; 12():105-10. PubMed ID: 917013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of inflammatory stimuli on murine plasma C4 and factor B concentrations.
    Garlepp MJ; Fritzler MJ; Hart DA
    Clin Invest Med; 1988 Oct; 11(5):341-6. PubMed ID: 3052973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced alternative complement pathway-dependent degradation of soluble immunoglobulin aggregates by macrophages.
    Daha MR; Van Es LA
    Immunology; 1981 Jul; 43(3):513-8. PubMed ID: 7251062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of chrysotile asbestos fibres with the complement system.
    Saint-Remy JM; Cole P
    Immunology; 1980 Oct; 41(2):431-7. PubMed ID: 6904360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The third component of complement (C3) bound to tumor target cells enhances their sensitivity to killing by activated macrophages.
    Bara S; Lint TF
    J Immunol; 1987 Feb; 138(4):1303-9. PubMed ID: 3100634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional active complement components secreted by guinea pig peritoneal macrophages.
    Brade V; Kreuzpaintner G
    Immunobiology; 1982 Apr; 161(3-4):315-21. PubMed ID: 7047377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages.
    Bentley C; Bitter-Suermann D; Hadding U; Brade V
    Eur J Immunol; 1976 Jun; 6(6):393-8. PubMed ID: 1033069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the possible involvement of complement component C3 in the initiation of acid hydrolase secretion by macrophages. I. Correlation between enzyme-releasing and complement-activating capacities of several secretagogues.
    Riches DW; Stanworth DR
    Immunology; 1981 Sep; 44(1):29-39. PubMed ID: 7275186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the alternative pathway of complement in childhood acute lymphoblastic leukemia.
    Kalwinsky DK; Urmson JR; Stitzel AE; Spitzer RE
    J Lab Clin Med; 1976 Nov; 88(5):745-56. PubMed ID: 1068203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.